14-day Premium Trial Subscription Sign Up For FreeGet Free
Nasdaq - Total Crash or Bounce-Up? Click To Watch.

$0.33 (-4.62%)

Volume: 39.314k

Closed: Sep 26, 2022

Hollow Logo Score: -6.268

Galmed Pharmaceuticals Ltd. Stock Forecast

$0.33 (-4.62%)

Volume: 39.314k

Closed: Sep 26, 2022

Score Hollow Logo -6.268
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSI min/max Values: [ 25 - 75 ] RSI14 is 31 and the stock is currently not being overbought or oversold
Last Reaction
Be the first to comment on GLMD

Galmed Pharmaceuticals Ltd. stock price ended on $0.33 on Monday after losing 4.62%
(Updated on Sep 26, 2022)


Sell candidate since 2022-09-16 Loss -24.23% PDF

The Galmed Pharmaceuticals Ltd. stock price fell by -4.62% on the last day (Monday, 26th Sep 2022) from $0.35 to $0.33. It has now fallen 8 days in a row. During the last trading day the stock fluctuated 3.00% from a day low at $0.33 to a day high of $0.34. The price has fallen in 8 of the last 10 days and is down by -23.11% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -17 thousand shares and in total, 39 thousand shares were bought and sold for approximately $12.97 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -37.85% during the next 3 months and, with a 90% probability hold a price between $0.17 and $0.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The Galmed Pharmaceuticals Ltd. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.38 and $0.43. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 30, 2022, and so far it has fallen -49.23%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0099 between high and low, or 3.00%. For the last week the stock has had daily average volatility of 9.37%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations For The Upcoming Trading Day Of Tuesday 27th

For the upcoming trading day on Tuesday, 27th we expect Galmed Pharmaceuticals Ltd. to open at $0.33, and during the day (based on 14 day Average True Range), to move between $0.29 and $0.37, which gives a possible trading interval of +/-$0.0416 (+/-12.59%) up or down from last closing price. If Galmed Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 25.19% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0500 (15.15%) our system find the risk reward not very attractive.

Is Galmed Pharmaceuticals Ltd. stock A Buy?

Galmed Pharmaceuticals Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.268

Strong Sell Candidate Unchanged

Predicted Opening Price for Galmed Pharmaceuticals Ltd. of Tuesday, September 27, 2022

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price September 27, 2022 Current price
$0.33 $0.33 (Undervalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.34 4.00 %
0.34 2.85 %
0.34 2.15 %
Current price: 0.33
Support 0.33 -0.15 %
0.33 -0.85 %
0.32 -2.00 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.41 24.28 %
0.40 20.09 %
0.38 15.15 %
Current price 0.33
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

Hot Stocks To Watch:

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 27 084 stocks, only a few dozen will trigger such a signal!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT